Reuters logo
4 months ago
BRIEF-Sanofi and Regeneron announce FDA approval of a once-monthly dosing option for Praluent
April 25, 2017 / 12:11 PM / 4 months ago

BRIEF-Sanofi and Regeneron announce FDA approval of a once-monthly dosing option for Praluent

April 25 (Reuters) - Sanofi

* Sanofi and Regeneron announce FDA approval of a new once-monthly dosing option for Praluent (alirocumab) injection

* Sanofi and Regeneron announce FDA approval of a new once-monthly dosing option for Praluent (alirocumab) injection

* Monthly dosing schedule now approved in both United States and European Union Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below